ACCENDRA HEALTH INC/VA/ (ACH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250M 500M 750M Q3 '24: 686.8M Q4 '24: 695M Q1 '25: 673.9M Q2 '25: 681.9M Q3 '25: 697.3M Q4 '25: 709M Q1 '26: 627.8M Q2 '26: 613.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 200M 400M 600M Q2 '23: 519.4M Q3 '23: 538.5M Q4 '23: 569.9M Q1 '24: 535.5M Q2 '24: 544.2M Q3 '24: 559.7M Q4 '24: 579.8M Q1 '25: 526M Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '25

Operating Income Quarterly

-300M -200M -100M 0 100M 200M 300M Q3 '24: 31.1M Q4 '24: -272.7M Q1 '25: 19.8M Q2 '25: -39.7M Q3 '25: 26.5M Q4 '25: 20.9M Q1 '26: 17.1M Q2 '26: -35.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-900M -600M -300M 0 300M 600M 900M Q3 '24: -12.8M Q4 '24: -296.1M Q1 '25: -25M Q2 '25: -869.1M Q3 '25: -150.3M Q4 '25: -56.3M Q1 '26: -6.5M Q2 '26: -89.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 150M 300M 450M Q3 '24: 355.1M Q4 '24: 324.4M Q1 '25: 354.6M Q2 '25: 357.3M Q3 '25: 375.1M Q4 '25: 385.7M Q1 '26: 349.8M Q2 '26: 349.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-180M -120M -60M 0 60M 120M 180M Q3 '24: 27.3M Q4 '24: 71M Q1 '25: -35.1M Q2 '25: 37.6M Q3 '25: -172.5M Q4 '25: 68.2M Q1 '26: -50.1M Q2 '26: -26M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-270M -180M -90M 0 90M 180M 270M Q3 '24: -30.3M Q4 '24: 48.7M Q1 '25: -80.9M Q2 '25: -20M Q3 '25: -246.9M Q4 '25: 55.1M Q1 '26: -91.7M Q2 '26: -73.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '24: 76.3M Q2 '24: 76.7M Q3 '24: 78.5M Q1 '25: 77.3M Q2 '25: 76.9M Q3 '25: 77.3M Q1 '26: 76.4M Q2 '26: 76.7M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q3 '24: -0.63 Q4 '24: -4.73 Q1 '25: -4.76 Q2 '25: -15.64 Q3 '25: -17.42 Q4 '25: -14.32 Q1 '26: -14.08 Q2 '26: -3.94 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.